Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study (vol 11, 683502, 2021)
FRONTIERS IN ONCOLOGY（2022）
摘要
[This corrects the article DOI: 10.3389/fonc.2021.683502.].
更多查看译文
关键词
anlotinib, anti-PD-1 antibody, angiogenesis, immunotherapy, serum cytokine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要